» Articles » PMID: 27694108

The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity

Abstract

Background: Asian Americans (AA) are the fastest growing U.S. population, and when properly distinguished by their ethnic origins, exhibit substantial heterogeneity in socioeconomic status, health behaviors, and health outcomes. Cancer is the second leading cause of death in the United States, yet trends and current patterns in the mortality burden of cancer among AA ethnic groups have not been documented.

Methods: We report age-adjusted rates, standardized mortality ratios, and modeled trends in cancer-related mortality in the following AA ethnicities: Asian Indians, Chinese, Filipinos, Japanese, Koreans, and Vietnamese, from 2003 to 2011, with non-Hispanic whites (NHW) as the reference population.

Results: For most cancer sites, AAs had lower cancer mortality than NHWs; however, mortality patterns were heterogeneous across AA ethnicities. Stomach and liver cancer mortality was very high, particularly among Chinese, Koreans, and Vietnamese, for whom these two cancer types combined accounted for 15% to 25% of cancer deaths, but less than 5% of cancer deaths in NHWs. In AA women, lung cancer was a leading cause of death, but (unlike males and NHW females) rates did not decline over the study period.

Conclusions: Ethnicity-specific analyses are critical to understanding the national burden of cancer among the heterogeneous AA population.

Impact: Our findings highlight the need for disaggregated reporting of cancer statistics in AAs and warrant consideration of tailored screening programs for liver and gastric cancers. Cancer Epidemiol Biomarkers Prev; 25(10); 1371-82. ©2016 AACR.

Citing Articles

Refinement of a meaning-centered counseling program for Chinese patients with advanced cancer: integrating cultural adaptation and implementation science approaches.

Lui F, Zhang Q, Bao G, Narang B, Chen R, Niu Y BMC Health Serv Res. 2025; 25(1):85.

PMID: 39815347 PMC: 11736934. DOI: 10.1186/s12913-024-12124-3.


Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022.

Puhr H, Winkler E, Preusser M ESMO Open. 2025; 10(1):104093.

PMID: 39754982 PMC: 11758121. DOI: 10.1016/j.esmoop.2024.104093.


Shattering the monolith: burden of gastrointestinal cancer in Asian Americans, Native Hawaiians, and Pacific Islanders in the United States.

Yoon J, Shah S, Lin J, Kim M, Itzkowitz S, Wang C Lancet Reg Health Am. 2024; 41:100954.

PMID: 39650260 PMC: 11625213. DOI: 10.1016/j.lana.2024.100954.


Developing the Meaning-Centered Program for Chinese Americans with Advanced Cancer: Applying Cultural Adaptation Frameworks.

Lui F, Chen Z, Niu Y, Breitbart W, Gany F, Leng J Asian Am J Psychol. 2024; 15(3):262-273.

PMID: 39430038 PMC: 11487614. DOI: 10.1037/aap0000318.


Survival disparities among racial groups with hepatic malignant tumors.

Han D, Zhang Z, Deng J, Du H World J Gastrointest Oncol. 2024; 16(7):2999-3010.

PMID: 39072178 PMC: 11271794. DOI: 10.4251/wjgo.v16.i7.2999.


References
1.
Arias E, Schauman W, Eschbach K, Sorlie P, Backlund E . The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2. 2008; (148):1-23. View

2.
Cheng I, Le G, Noone A, Gali K, Patel M, Haile R . Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev. 2014; 23(11):2250-65. PMC: 5738466. DOI: 10.1158/1055-9965.EPI-14-0493. View

3.
Kawaguchi T, Koh Y, Ando M, Ito N, Takeo S, Adachi H . Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study. J Clin Oncol. 2016; 34(19):2247-57. DOI: 10.1200/JCO.2015.64.2322. View

4.
Choi K, Kwak M, Lee H, Jun J, Hahm M, Park E . Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev. 2009; 18(5):1390-8. DOI: 10.1158/1055-9965.EPI-08-0940. View

5.
Devesa S, Donaldson J, Fears T . Graphical presentation of trends in rates. Am J Epidemiol. 1995; 141(4):300-4. DOI: 10.1093/aje/141.4.300. View